A61K 51/1075
The antibody being against an enzyme
Official title: {the antibody being against an enzyme}
A61K51/1075 (The antibody being against an enzyme) appears on 65 US grants and 116 published applications in this corpus.
Search patents in A61K- Granted patents
- 65
- Published applications
- 116
- Assignees
- 63
- Inventors
- 209
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 5 |
| 2002 | 1 | 2 |
| 2003 | 1 | 1 |
| 2004 | 1 | 2 |
| 2005 | 1 | 4 |
| 2006 | 1 | 0 |
| 2007 | 0 | 3 |
| 2008 | 0 | 1 |
| 2009 | 2 | 3 |
| 2010 | 4 | 3 |
| 2011 | 2 | 3 |
| 2012 | 3 | 7 |
| 2013 | 2 | 7 |
| 2014 | 2 | 2 |
| 2015 | 6 | 5 |
| 2016 | 5 | 16 |
| 2017 | 5 | 4 |
| 2018 | 3 | 4 |
| 2019 | 7 | 5 |
| 2020 | 4 | 5 |
| 2021 | 3 | 3 |
| 2022 | 5 | 10 |
| 2023 | 2 | 6 |
| 2024 | 0 | 7 |
| 2025 | 4 | 3 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Humanised anti kallikrein-2 antibody2 Sep 2025US 12,404,343 B2Janssen Biotech, Inc.
- Therapeutic agents and uses thereof12 Aug 2025US 12,383,637 B2Janssen Biotech, Inc.
- Anti-FAP antibodies and methods of use29 Apr 2025US 12,286,486 B2Roche Glycart AG
- Granzyme B directed imaging and therapy11 Mar 2025US 12,246,075 B2The General Hospital Corporation
- Anti-transglutaminase 2 antibodies8 Aug 2023US 11,718,686 B2Lifearc
- In vivo imaging of an als biomarker and means therefor8 Oct 2026US 2026/0306683 A1AL-S Pharma AG
- Humanised Anti Kallikrein-2 Antibody3 Sep 2026US 2026/0258157 A1Janssen Biotech, Inc.
- Compositions and methods for the treatment of prostate cancer30 Jul 2026US 2026/0216384 A1Janssen Biotech, Inc.
- Radiolabelled Compounds9 Apr 2026US 2026/0097140 A1Peter MacCallum Cancer Institute
- Therapeutic agents and uses thereof19 Feb 2026US 2026/0048159 A1Janssen Biotech, Inc.
Most cited
By later US patents
- Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression105US 6,767,704 B2Thomas Jefferson University · 2004
- Compositions and methods for identifying and targeting cancer cells of alimentary canal origin84US 7,479,376 B2Thomas Jefferson University · 2009
- Immunoglobulin molecules with improved characteristics51US 8,163,881 B2Board of Regents, The University of Texas System · 2012
- Method of detecting endometriosis37US 6,540,980 B1Center for Molecular Medicine and Immunology · 2003
- Anti-FAP antibodies and methods of use31US 9,011,847 B2Roche Glycart AG · 2015